NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.7 | – | – | – | – | – | – | – | |
| 24.9 | 22.1 | 23.8 | 17.5 | 41.1 | 12.8 | 4.7 | 7.1 | 13.9 | 11.2 | 6.3 | 2.3 | 5.7 | 12.0 | 7.6 | 8.8 | 10.5 | 8.9 | 9.8 | 9.7 | 10.4 | 30.3 | 5.0 | 33.0 | 19.9 | 24.3 | 4.7 | 1.2 | 1.9 | 12.9 | |
| 4.9 | 3.7 | 4.5 | 8.4 | 7.6 | 3.7 | 2.2 | 4.6 | 3.4 | 4.3 | 6.0 | 2.9 | 2.7 | 8.4 | 13.4 | 3.2 | 18.1 | – | 54.1 | 348.2 | 19.5 | 106.0 | 3.5 | 2.7 | 2.8 | 3.6 | 1.2 | 0.8 | 3.1 | 7.9 | |
| 22.2 | 21.2 | 22.7 | 16.7 | 44.6 | 16.6 | 7.9 | 10.2 | 14.8 | 12.6 | 8.0 | 3.2 | 7.1 | 15.0 | 9.2 | 11.9 | 12.2 | 9.7 | 10.4 | 10.5 | 11.5 | 31.1 | 5.1 | 34.5 | 18.6 | 24.2 | 3.9 | 1.0 | 1.7 | 13.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 250.6 | – | – | – | – | – | – | – | – | – | 8.2 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 5.4 | – | 45.3 | – | – | – | – | – | – | – | – | 8.4 | – | – | – | – | – | – | – | |
| -4.7% | -3.4% | -10.4% | -4.9% | -4.2% | -8.6% | -20.4% | -12.5% | -6.6% | -6.8% | -8.4% | 18.4% | -31.8% | 2.2% | -7.2% | -19.5% | -16.5% | -3.2% | -7.7% | -3.8% | -7.2% | -1.0% | 11.9% | -9.4% | -10.6% | -17.3% | -71.9% | -180.2% | -92.6% | -29.2% | |
| Margins | ||||||||||||||||||||||||||||||
| 117.4% | 100.0% | 100.0% | 100.0% | 100.0% | 94.6% | 92.6% | 86.2% | 82.7% | 71.5% | 45.8% | 46.0% | 61.1% | 57.0% | 83.9% | 69.4% | 62.5% | 74.1% | 85.8% | 85.2% | 81.7% | 90.1% | 98.0% | 81.4% | 87.3% | 75.6% | 76.5% | 59.3% | 68.8% | 100.0% | |
| -166.7% | -84.5% | -100.9% | -97.9% | -128.1% | -331.7% | -105.5% | -62.3% | -64.7% | -144.6% | -73.1% | -13.2% | -91.6% | -132.3% | -17.8% | -173.4% | -173.9% | -80.7% | -8.2% | -12.7% | -68.2% | -19.4% | 57.6% | -383.9% | -248.5% | -437.8% | -261.0% | -152.5% | -106.9% | -236.8% | |
| -144.9% | -61.4% | -84.2% | -93.0% | -188.7% | -322.7% | -113.3% | -43.9% | -89.2% | -146.6% | -71.1% | -12.0% | -38.1% | -142.5% | -23.9% | -187.4% | -211.7% | -108.8% | -26.9% | -35.2% | -92.8% | -31.4% | 57.1% | -384.5% | -290.6% | -514.0% | -400.0% | -306.3% | -120.9% | -297.1% | |
| -115.9% | -75.6% | -246.9% | -86.6% | -173.5% | -109.8% | -96.3% | -89.4% | -92.2% | -76.0% | -52.9% | 41.6% | -182.6% | 26.5% | -54.9% | -172.7% | -172.9% | -28.6% | -75.7% | -36.5% | -74.6% | -29.3% | 59.0% | -309.7% | -209.6% | -419.6% | -336.4% | -214.7% | -180.0% | -377.8% | |
| Returns | ||||||||||||||||||||||||||||||
| -28.5% | -10.3% | -15.8% | -44.4% | -35.1% | -92.5% | -52.0% | -28.4% | -21.8% | -56.6% | -68.2% | -15.3% | -18.1% | -100.1% | -41.8% | -67.7% | -365.5% | – | -148.4% | -1,262.7% | -174.2% | -110.1% | 39.7% | -31.4% | -41.3% | -77.1% | -100.4% | -210.8% | -195.9% | -182.6% | |
| -24.1% | -8.3% | -13.6% | -17.0% | -15.5% | -37.5% | -17.7% | -7.6% | -13.7% | -21.6% | -20.1% | -4.5% | -6.1% | -17.8% | -7.3% | -22.1% | -34.5% | -37.3% | -12.2% | -16.2% | -27.0% | -19.0% | 31.7% | -22.3% | -28.9% | -46.9% | -51.8% | -69.4% | -39.2% | -58.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -18 | -15 | -25 | -33 | 184 | 301 | 297 | 329 | 105 | 179 | 374 | 263 | 119 | 213 | 244 | 217 | 141 | 130 | 117 | 196 | 190 | 272 | 114 | 169 | -185 | -7.8 | -70 | -16 | -24 | 5.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 46.8 | – | – | – | – | – | – | – | – | – | 0.2 | – | – | – | – | – | – | – | |
| 84.6% | 81.1% | 86.2% | 38.2% | 44.1% | 40.5% | 34.1% | 26.6% | 62.7% | 38.1% | 29.6% | 29.6% | 33.9% | 17.8% | 17.4% | 32.6% | 9.4% | -20.7% | 8.2% | 1.3% | 15.5% | 17.3% | 79.9% | 71.1% | 70.0% | 60.8% | 51.6% | 32.9% | 20.0% | 32.0% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 1.2 | 1.6 | 2.4 | 0.4 | 1.3 | 1.9 | 1.6 | 1.4 | 2.6 | 2.9 | 1.2 | 3.5 | – | 3.6 | 39.1 | 2.8 | 3.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | |
| Per Share | ||||||||||||||||||||||||||||||
| -6.60 | -5.43 | -8.76 | -16.95 | -34.79 | -70.58 | -29.16 | -12.54 | -19.48 | -32.32 | -25.85 | -5.35 | -5.57 | -16.58 | -6.05 | -17.79 | -22.45 | -21.00 | -6.37 | -9.19 | -16.50 | -9.30 | 56.74 | -37.77 | -37.33 | -42.87 | -29.51 | -21.79 | -8.68 | -9.73 | |
| 4.55 | 8.84 | 10.40 | 18.24 | 18.44 | 21.87 | 25.73 | 28.55 | 21.85 | 22.05 | 36.37 | 44.58 | 14.64 | 11.63 | 25.36 | 9.49 | 10.61 | 19.30 | 23.73 | 26.13 | 17.78 | 29.60 | 99.38 | 9.82 | 12.84 | 8.34 | 7.38 | 7.11 | 7.18 | 3.27 | |
| 23.17 | 52.80 | 55.29 | 38.20 | 99.25 | 76.31 | 56.10 | 44.12 | 89.35 | 57.06 | 37.93 | 35.01 | 30.87 | 16.55 | 14.46 | 26.27 | 6.14 | -11.65 | 4.30 | 0.73 | 9.47 | 8.45 | 143.04 | 120.47 | 90.49 | 55.61 | 29.39 | 10.34 | 4.43 | 5.32 | |
| -5.28 | -6.68 | -25.67 | -15.80 | -32.00 | -24.02 | -24.77 | -25.51 | -20.14 | -16.75 | -19.25 | 18.53 | -26.72 | 3.08 | -13.92 | -16.40 | -18.33 | -5.52 | -17.97 | -9.54 | -13.26 | -8.67 | 58.63 | -30.43 | -26.92 | -35.00 | -24.82 | -15.27 | -12.92 | -12.37 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.